Exploring HCM Diagnosis and Treatment Options:  The New Frontier of Cardiac Myosin Inhibitors 

By participating in this education, participants should be able to:

• Identify innovative diagnostic approaches to differentiate HCM, providing insights into future directions in the field.  
• Create treatment plans with innovative approaches while considering evolving guidelines for HCM management.  
• Describe the role of the Cardiac care team in providing diagnosis and treatment for HCM, considering
  holistic patient care.  
• Develop strategies to mitigate disparities, ensuring equitable access to specialized HCM care and interventions across diverse patient populations.

We are grateful to these distinguished faculty who contributed to this collection:

Chair

Matthew Martinez, MD, FACC 

Faculty

Anjali Owens, MD

Purvi Parwani, MD, FACC 

Robyn Bryde, MD  

Educational Grant Support Provided By: Bristol Myers Squibb

Page Launched: June 2024